Søgeresultater - deJesus, Edwin

Refine Results
  1. 1
    Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in a real-world setting

    Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in... af Rolle, Charlotte-Paige, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

    Udgivet 2020
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  2. 2
    Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced, patients living with HIV

    Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced, patients liv... af Rolle, Charlotte-Paige, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

    Udgivet 2021
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  3. 3
    2482. Clinical Outcomes of Once-Daily Darunavir in Treatment-Experienced Patients with Darunavir Resistance Associated Mutations Through 48 Weeks of Treatment

    2482. Clinical Outcomes of Once-Daily Darunavir in Treatment-Experienced Patients with Darunavir Resistance Associated Mutations Through 48 Weeks of Treatment af Rolle, Charlotte-Paige M, Marquez, Omar, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  4. 4
    Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV

    Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV af Rolle, Charlotte-Paige, Nguyen, Vu, Patel, Kiran, Cruz, Dan, DeJesus, Edwin, Hinestrosa, Federico

    Udgivet 2021
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  5. 5
    661. Ibalizumab Efficacy and Safety Through 48 Weeks of Treatment: Results of an Expanded Access Protocol (TMB-311)

    661. Ibalizumab Efficacy and Safety Through 48 Weeks of Treatment: Results of an Expanded Access Protocol (TMB-311) af Emu, Brinda, DeJesus, Edwin, Berhe, Mezgebe, Leider, Jason, Creticos, Catherine, Weinheimer, Steve, Cohen, Zvi

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  6. 6
    1012. Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected virologically-suppressed older adults in a real-world setting

    1012. Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected virologically-suppressed older adults in a real-... af Rolle, Charlotte-Paige M, Nguyen, Vu, Patel, Kiran, Cruz, Dan, Hinestrosa, Federico, DeJesus, Edwin

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  7. 7
    889. Early Discontinuations and Adverse Events Among Treatment-Naïve Patients Initiating Integrase Inhibitors in a Real-world Setting

    889. Early Discontinuations and Adverse Events Among Treatment-Naïve Patients Initiating Integrase Inhibitors in a Real-world Setting af Rolle, Charlotte-Paige M, Castano, Jamie, Nguyen, Vu, Patel, Kiran, Hinestrosa, Federico, DeJesus, Edwin

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  8. 8
    Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data

    Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data af Rodriguez, Allan E, DeJesus, Edwin, Williams, Vanessa, Irlbeck, David, Ross, Lisa, Ha, Belinda, Lancaster, Charles T

    Udgivet 2010
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  9. 9
    Safety and Efficacy of Enfuvirtide in Combination with Darunavir-Ritonavir and an Optimized Background Regimen in Treatment-Experienced Human Immunodeficiency Virus-Infected Patients: the Below the Level of Quantification Study

    Safety and Efficacy of Enfuvirtide in Combination with Darunavir-Ritonavir and an Optimized Background Regimen in Treatment-Experienced Human Immunodeficiency Virus-Infected Patien... af DeJesus, Edwin, Gottlieb, Michael S., Gathe, Joseph C., Greenberg, Michael L., Guittari, Carol Jean, Zolopa, Andrew R.

    Udgivet 2008
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  10. 10
    Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults

    Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-In... af Jacobson, Jeffrey M., Kuritzkes, Daniel R., Godofsky, Eliot, DeJesus, Edwin, Larson, Jeffrey A., Weinheimer, Steven P., Lewis, Stanley T.

    Udgivet 2009
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  11. 11
    Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults

    Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults af DeJesus, Edwin, Saleh, Soundos, Cheng, Sue, van der Mey, Dorina, Becker, Corina, Frey, Reiner, Unger, Sigrun, Mueck, Wolfgang

    Udgivet 2019
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  12. 12
    2486. Clinical Outcomes of Patients Treated with Dolutegravir Functional Monotherapy or Dolutegravir plus an Active Non-cytosine Nucleoside Analog: A Retrospective Observational Cohort Study of Treatment-Experienced Patients

    2486. Clinical Outcomes of Patients Treated with Dolutegravir Functional Monotherapy or Dolutegravir plus an Active Non-cytosine Nucleoside Analog: A Retrospective Observational Co... af Rolle, Charlotte-Paige M, Bryant, Beth, Tucker, Colton J, Camila Castro, Maria, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  13. 13
    1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants

    1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants af Towner, William, DeJesus, Edwin, Schrader, Shannon, De Vente, Jerome, McGary, Colleen, Zogheib, Mohammed, Weinheimer, Steven, Mesquita, Pedro

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  14. 14
    A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)

    A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice... af Kumar, Princy N, Salvato, Patricia, LaMarca, Anthony, DeJesus, Edwin, Patel, Parul, McClernon, Daniel, Florance, Allison, Shaefer, Mark S

    Udgivet 2009
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  15. 15
    Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

    Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice af Lackey, Philip, Mills, Anthony, Carpio, Felix, Hsu, Ricky, DeJesus, Edwin, Pierone, Gerald, Henegar, Cassidy, Fusco, Jennifer, Fusco, Gregory, Wohlfeiler, Mike

    Udgivet 2016
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  16. 16
    Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects

    Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects af DeJesus, Edwin, Piliero, Peter J., Summers, Kim, Wire, Mary Beth, Stein, Daniel S., Masterman, Amanda, Lou, Yu, Min, Sherene S., Shelton, Mark J.

    Udgivet 2006
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  17. 17
    A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus

    A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus af Thompson, Melanie, Saag, Michael, DeJesus, Edwin, Gathe, Joseph, Lalezari, Jay, Landay, Alan L., Cade, Jerry, Enejosa, Jeffrey, Lefebvre, Eric, Feinberg, Judith

    Udgivet 2016
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  18. 18
    Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults

    Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults af Gallant, Joel E., Thompson, Melanie, DeJesus, Edwin, Voskuhl, Gene W., Wei, Xuelian, Zhang, Heather, White, Kirsten, Cheng, Andrew, Quirk, Erin, Martin, Hal

    Udgivet 2017
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  19. 19
    Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide

    Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide af Sax, Paul E., DeJesus, Edwin, Crofoot, Gordon, Ward, Douglas, Benson, Paul, Dretler, Robin, Mills, Anthony, Brinson, Cynthia, Wei, Xuelian, Collins, Sean E., Cheng, Andrew

    Udgivet 2018
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  20. 20
    Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

    Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT af Smith, Kimberly Y, Weinberg, Winkler G, DeJesus, Edwin, Fischl, Margaret A, Liao, Qiming, Ross, Lisa L, Pakes, Gary E, Pappa, Keith A, Lancaster, C Tracey

    Udgivet 2008
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:

Søgeredskaber: